Frankfurt
15.11.24
18:48 Uhr
4,440 Euro
-0,040
-0,89 %
-0,89 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.10. | NutriBand Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 31.10. | Nutriband, Inc.: Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application | 123 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / October 31, 2024 / Nutriband (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that theChinese National Intellectual Property Administrant (CNIPA) has fully issued its patent titled... ► Artikel lesen | |
| 17.10. | Nutriband, Inc.: Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica | 482 | ACCESSWIRE | The approved product will be exclusively distributed through Farmavision S.A. throughout Costa Rica ORLANDO, FL / ACCESSWIRE / October 17, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced... ► Artikel lesen | |
| NUTRIBAND Aktie jetzt für 0€ handeln | |||||
| 02.10. | Nutriband, Inc.: Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 | 177 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / October 2, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on October 17... ► Artikel lesen | |
| 24.09. | Nutriband erhält Patent in China für missbrauchsresistentes Pflaster | 6 | Investing.com Deutsch | ||
| 24.09. | Nutriband secures patent in China for abuse-deterrent patch | 2 | Investing.com | ||
| 24.09. | Nutriband, Inc.: Nutriband Receives China Patent Notice of Allowance for Its Aversa Abuse Deterrent Transdermal Technology | 191 | ACCESSWIRE | Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for the patent application covering its Platform AVERSA abuse deterrent transdermal technologyNutriband... ► Artikel lesen | |
| 20.09. | BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Inks Licensing Agreement to Use Bitrex(R) Aversive Agent for Flagship Product | 1 | iNVEZZ.com | ||
| 20.09. | Nutriband, Inc.: Nutriband Licenses Bitrex Brand Aversive Agent for Its Lead Product - Aversa Fentanyl Transdermal Patch | 631 | ACCESSWIRE | Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive agent for its Aversa Fentanyl abuse deterrent fentanyl transdermal... ► Artikel lesen | |
| 18.09. | NutriBand Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 16.09. | Nutriband plant Aktienrückkauf im Wert von 1 Million Dollar | 1 | Investing.com Deutsch | ||
| 16.09. | Nutriband to repurchase $1 million in common stock | 1 | Investing.com | ||
| 16.09. | Nutriband, Inc.: Nutriband Inc. Authorizes $1M Share Buyback Program | 323 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / September 16, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of September... ► Artikel lesen | |
| 04.09. | BioMedNewsBreaks - Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl Update | 3 | iNVEZZ.com | ||
| 04.09. | Nutriband, Inc.: Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 | 273 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second quarter ended July 31, 2024. The Company reported a strong... ► Artikel lesen | |
| 03.09. | NutriBand Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 19.07. | Nutriband, Inc.: Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 | 334 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / July 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on July 25, 2024... ► Artikel lesen | |
| 15.07. | Nutriband, Inc.: Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA Abuse Deterrent Technology | 252 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / July 15, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received a Notice of Allowance from... ► Artikel lesen | |
| 20.06. | Nutriband Inc.: Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl | 439 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / June 20, 2024 / Nutriband Inc.("Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) provides an update on its Aversa Fentanyl product development program to shareholders as it aims to complete... ► Artikel lesen | |
| 03.06. | Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year | 283 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / June 3, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today reported Q1 revenues of $408,532 emphasizing its focus on expanding the company's Kinesiology Tape manufacturing... ► Artikel lesen |
Seite:
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 20,305 | -0,95 % | Bayer AG Aktie: Trends und Prognosen | ||
| PFIZER | 23,600 | +0,19 % | Die Anleger von Moderna zittern vor Robert F. Kennedy, auch BioNTech gerät unter Druck, Pfizer folgt dem Beispiel und Novo Nordisk bekommt es mit immer mehr Konkurrenz zu tun | Rund zwei Monate vor dem Amtsantritt von Donald Trump nimmt dessen Kabinett langsam Formen an. Die Presse findet für die bisherigen Entscheidungen illustre Worte, sehr beliebt ist etwa das "Gruselkabinett".... ► Artikel lesen | |
| GILEAD SCIENCES | 83,97 | +0,10 % | Gilead's Livdelzi Shows Sustained Efficacy, Long-Term Safety In PBC Management | FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) announced data from a two-and-a-half-year interim analysis from the ongoing Phase 3 ASSURE study, which showed that 81% of participants with... ► Artikel lesen | |
| GSK | 15,780 | -4,01 % | Dividendenbekanntmachungen (14.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN PROPERTY INCOME TRUST LIMITED GB0033875286 0,003 GBP 0,0036 EUR AFFILIATED MANAGERS GROUP INC US0082521081 0,01 USD 0,0094... ► Artikel lesen | |
| MERCK & CO | 91,50 | 0,00 % | Merck & Co: Normalerweise ein Fels in der Brandung, aktuell eher Fallobst | Kursverluste in dieser Größenordnung kommen bei Merck alle Jubeljahre vor. Gelegenheit oder Zwischenstopp in Richtung Keller Den vollständigen Artikel lesen ... ► Artikel lesen | |
| TILRAY BRANDS | 1,256 | -1,72 % | Tilray Brands, Inc.: Tilray Medical bringt erste in Deutschland angebaute kommerzielle medizinische Cannabisprodukte unter neu erweiterter Anbaulizenz auf den Markt | NEUMÜNSTER, Deutschland, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. ("Tilray Brands") (NASDAQ: TLRY und TSX: TLRY) und ein weltweit führender Anbieter... ► Artikel lesen | |
| INNOCAN PHARMA | 0,142 | -1,05 % | Jetzt investieren? Q3 Zahlen und FDA-News "ante portas"?! | ||
| TAAT GLOBAL ALTERNATIVES | 0,120 | -0,41 % | TAAT Global Alternatives Inc (2): TAAT to issue 11.25M shares for debt of $1.35M | ||
| MYDECINE INNOVATIONS GROUP | 0,002 | 0,00 % | Mydecine Innovations Group Inc - Suspension of Trading | Mydecine Innovations Group Inc - Suspension of Trading
PR Newswire
LONDON, United Kingdom, October 10
SUSPENSION OF TRADINGVancouver, British Columbia, 10 October 2024-... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 8,600 | -3,91 % | Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,017 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake to complete $3.6M private placement | ||
| PSYCHED WELLNESS | 0,009 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Announces Supply Chain Disruption in the US | Toronto, Ontario--(Newsfile Corp. - August 6, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched"), a life sciences company focused on the production and distribution of... ► Artikel lesen | |
| COMPASS PATHWAYS | 4,940 | +2,92 % | Compass Pathways plc: Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates | Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression now expected in second quarter 2025 COMP006 data will now be announced after 26-week time point... ► Artikel lesen | |
| ROCKET LAB USA | 18,100 | +0,11 % | Rocket Lab USA, Inc: Rocket Lab Schedules Next Launch for Constellation Operator Kinéis | The mission will be the third of five dedicated Electron launches booked by the French Internet-of-Things constellation operator
Rocket Lab USA, Inc ("Rocket Lab" or the "Company") (Nasdaq: RKLB)... ► Artikel lesen | |
| JUVA LIFE | 0,023 | 0,00 % | Juva Life Inc. Updates Shareholders on Financial Status and Upcoming Receivership Hearing | REDWOOD CITY, CA / ACCESSWIRE / November 5, 2024 / Juva Life Inc. (CSE:JUVA)(OTC EXPERT MARKET:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"), a life science company with both pharmaceutical research... ► Artikel lesen |
Das Unternehmen NUTRIBAND INC kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 4,440 Euro und damit -0,89 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NUTRIBAND INC finden Sie auf Wallstreet Online.
